Individualized exercise program for cancer patients undergoing chemotherapy
A Flexible Individualized ExeRcise Programme for Cancer Patients During ChEmotherapy
This study is testing a personalized exercise program designed for cancer patients undergoing chemotherapy to see if it can help them feel better and manage side effects like fatigue and weakness.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 50 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Dublin, Trinity College Academic / other |
| Drugs / interventions | chemotherapy, immunotherapy |
| Locations | 1 site (Dublin) |
| Trial ID | NCT06280885 on ClinicalTrials.gov |
What this trial studies
This study aims to assess the feasibility of a co-designed exercise program tailored for cancer patients receiving chemotherapy. The program focuses on addressing the physical and logistical barriers that patients face while encouraging regular exercise, which has been shown to alleviate chemotherapy side effects such as fatigue and muscle weakness. By involving patients and healthcare professionals in the design process, the study seeks to create a flexible and individualized exercise intervention that can adapt to the unpredictable nature of chemotherapy treatment. The ultimate goal is to enhance patients' quality of life and overall well-being during their treatment.
Who should consider this trial
Good fit: Ideal candidates for this study are adults over 18 with stage I to IIIc breast, ovarian, or colorectal cancer who are scheduled to receive chemotherapy with curative intent.
Not a fit: Patients with advanced or metastatic disease, those receiving concurrent chemoradiotherapy, or high-dose chemotherapy during hospital admission may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly improve the quality of life for cancer patients undergoing chemotherapy by reducing treatment-related side effects.
How similar studies have performed: Previous studies have indicated that exercise interventions during chemotherapy can be beneficial, but this approach of co-designing a flexible program is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged \>18. * Histological confirmed diagnosis of stage I to IIIc breast, ovarian or colorectal cancer. * Scheduled to receive chemotherapy ± immunotherapy with curative intent. * Medical clearance from oncologist to partake in regular exercise in accordance with American College of Sports Medicine (ACSM) preparticipation screening algorithm. * Ability to provide written informed consent. Exclusion Criteria: * Advanced/metastatic disease. * Scheduled to receive concurrent chemoradiotherapy. * Scheduled to receive high-dose chemotherapy during hospital admission.
Where this trial is running
Dublin
- St James's Hospital — Dublin, Ireland (Recruiting)
Study contacts
- Study coordinator: Emer Guinan, PhD
- Email: guinane1@tcd.ie
- Phone: +35318962126
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.